Descroix-Vernier EthicScience Award: click here

Created in 2013 by the Pro Anima Scientific Committee, and financed via the EthicScience Action Fund and generous sponsorship, the EthicScience Prize is awarded every two years to scientific programs that have not involved the use of animals, and present leading advances in both innovation and ethics.

In 2022, for its 5th edition, the Prix EthicScience will become the Prix Descroix-Vernier EthicScience. The Descroix-Vernier Foundation, which for decades has supported numerous humanitarian, environmental and animal causes, and whose mission is to save as many lives as possible, considers the challenges of non-animal research to be crucial.

The prize rewards three scientific programs: the first two categories, “Innovation” and “Applicability”, contribute to the development of non-animal research in its various aspects, and are each endowed with 50,000 euros. In addition to these 2 awards, the “Jury’s Prize” is endowed with 10,000 euros. This prize is designed to encourage promising research and/or a team for the exceptional quality of its work.

Winners 2023 and press release : click here

“Innovation” category: Dr Agathe FIGAROL – FEMTO ST – Université de Franche-Comté, for project: 3D Glimpse – Tumor on a chip to fight glioblastoma

“Development and applicability” category: Dr Julien MARIE and Sophie LEON – Centre de Recherche en Cancérologie de Lyon, for project: Innovative development and application of an alternative method to animals in cancer research.

Jury Prize: Nicolas AZNAR – Centre de Recherche en Cancérologie de Lyon, for project: NEXPOCAN – Next generation patient derived organic for enhanced physiology and cancer modeling

The programs rewarded in 2020 were :

Development of the VALITOX cellular toxicology program – AOP (Anti Oxidant Power) laboratory: the aim is to offer an alternative method without animal testing in the regulatory field of acute oral toxicity in humans.

Bio-printing of human tissue – Poietis laboratory in partnership with AOP laboratory: Partnership developed to apply LUCS / VALITOX technology to bio-printed human tissue models.

Alfred Kastler Biology Prize, LFDA : click here

The LFDA Alfred Kastler Biology Prize was founded in 1984 in memory of Professor Alfred Kastler, Nobel Prize winner, member of the Institute, co-founder of the LFDA and its President from 1979 to 1984. The €4,000 prize is intended to encourage research and the application of methods that avoid the traumatic experimental use of animals.

Winner of the 2023 prize: Alexandra Benchoua, Director of Research at the Center for Stem Cell Studies at the Stem Cell Institute for the Treatment and Study of Monogenic Diseases (I-STEM), for her development of an experimental method that does not require the use of animals, as part of the search for a new treatment for neurological diseases (autism, myopathies, etc.) or psychiatric disorders such as schizophrenia.

In 2021, it was awarded to Vasiliki Kalatzis, Inserm research director at the Montpellier Neuroscience Institute, for her work on blindness without animal experimentation : interview

In 2017, the prize was awarded to Mohammed Moudjou, Vincent Béringue and Jérôme Chapuis, researchers in virology and molecular immunology at INRA, for developing an alternative method to the animal model for diagnosing prion diseases in humans and animals.

EPAA (European Partnership for Alternative Approaches to Animal Testing) : click here

Every two years since 2014, EPAA has awarded a “3R Scientific Prize” (10,000 euros) to promote European research into alternative approaches to animal experimentation.

2024: Jakub Tomek, University of Oxford, for project: “Computational model of human ventricular cardiomyocytes for arrhythmia research and drug safety assessment”.

3R Award presented by FC3R: click here

Each year, the FC3R awards the “Research” prize and the “Culture of Care” prize.

Discover the 2024 winners here